The straight answer
Let's be honest with you: no peptide is a proven, approved treatment for nerve pain. There is one real bright spot worth knowing about, ARA-290 (cibinetide), which in small human trials eased nerve pain and even helped tiny nerve fibers grow back in people with sarcoidosis and diabetes. That is genuinely promising, but every trial was small and short, it was run mostly by the people who invented it, and no regulator has approved it anywhere. Everything else here is animal work or borrowed from other conditions. None of it should replace care that actually works.
What actually treats it
The treatments proven to reduce nerve pain today are specific medicines: duloxetine (an SNRI), the tricyclic antidepressant amitriptyline, and the gabapentinoids gabapentin and pregabalin, sometimes with a topical lidocaine patch. Just as important, treating the cause matters most, so getting blood sugar under control in diabetes, or treating the underlying disease, can slow or stop the damage. A doctor can find the cause and match the right treatment to you.
From our library
Compounds here with any tie to nerve pain (neuropathy) — rated honestly for this specific use.
- Emerging
ARA-290
Worth a lookThis is the only compound here with real human evidence for nerve pain itself. In several small phase 2 trials, people with painful small-fiber neuropathy from sarcoidosis had less pain and, remarkably, showed regrowth of the tiny nerve fibers in the cornea, a sign of nerve healing. A separate trial in type 2 diabetes with nerve pain found similar improvement plus better blood sugar. The catch: every trial had fewer than 65 people, lasted only 4 to 12 weeks, was run largely by the drug's original developers, and it is not approved or marketed anywhere. Promising and biologically sensible, but not proven, and only ever used under medical supervision with pharmaceutical-grade material.
- Early
BPC-157
SpeculativeBPC-157 helped rats regrow damaged nerves and recover movement after their sciatic nerve was cut. That is interesting, but it is all animal work. No human study has tested whether it does anything for nerve pain or nerve damage in people, and the version sold online is an unregulated gray-market product. The tie is a hopeful hint from rodents, not evidence it helps you.
- Early
Cerebrolysin
SpeculativeCerebrolysin is a mix of nerve-supporting peptides given by IV, used mainly for stroke and dementia recovery. A handful of small studies have looked at it for diabetic nerve pain, with mixed and low-quality results. It is not FDA-approved in the US, needs an IV under supervision, and the evidence for neuropathy specifically is thin. Worth being aware of, not something to count on.
Bottom line
If you live with nerve pain, ARA-290 (cibinetide) is the one peptide with a genuine thread of human evidence behind it, and even that is early and unapproved. The honest path to relief runs through proven medicines and treating the cause, not research chemicals.